NASDAQ:HQY - Healthequity Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $68.30 +0.45 (+0.66 %) (As of 05/24/2019 09:46 AM ET)Previous Close$67.85Today's Range$68.13 - $68.8952-Week Range$50.29 - $101.58Volume16,783 shsAverage Volume849,574 shsMarket Capitalization$4.28 billionP/E Ratio71.89Dividend YieldN/ABeta1.62 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers health reimbursement and flexible spending arrangements solutions; and Employee Retirement Income Security Act's plan administration and investment services. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah. Receive HQY News and Ratings via Email Sign-up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HQY Previous Symbol CUSIPN/A CIK1428336 Webhttp://www.healthequity.com/ Phone801-727-1000Debt Debt-to-Equity RatioN/A Current Ratio13.59 Quick Ratio13.58Price-To-Earnings Trailing P/E Ratio71.89 Forward P/E Ratio72.66 P/E Growth3 Sales & Book Value Annual Sales$287.24 million Price / Sales14.91 Cash Flow$1.2173 per share Price / Cash Flow56.11 Book Value$7.65 per share Price / Book8.93Profitability EPS (Most Recent Fiscal Year)$0.95 Net Income$73.90 million Net Margins25.73% Return on Equity13.59% Return on Assets12.88%Miscellaneous Employees1,141 Outstanding Shares62,718,000Market Cap$4.28 billion Next Earnings Date6/4/2019 (Confirmed) OptionableOptionable Healthequity (NASDAQ:HQY) Frequently Asked Questions What is Healthequity's stock symbol? Healthequity trades on the NASDAQ under the ticker symbol "HQY." How were Healthequity's earnings last quarter? Healthequity Inc (NASDAQ:HQY) released its quarterly earnings results on Monday, March, 18th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.06. The company earned $75.78 million during the quarter, compared to the consensus estimate of $74.28 million. Healthequity had a return on equity of 13.59% and a net margin of 25.73%. The firm's revenue was up 25.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.09 EPS. View Healthequity's Earnings History. When is Healthequity's next earnings date? Healthequity is scheduled to release their next quarterly earnings announcement on Tuesday, June 4th 2019. View Earnings Estimates for Healthequity. How can I listen to Healthequity's earnings call? Healthequity will be holding an earnings conference call on Tuesday, June 4th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8447916252. What guidance has Healthequity issued on next quarter's earnings? Healthequity issued an update on its FY20 earnings guidance on Monday, March, 18th. The company provided earnings per share guidance of $1.23-1.29 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.31. The company issued revenue guidance of $333-339 million, compared to the consensus revenue estimate of $336.89 million.Healthequity also updated its FY 2020 guidance to $1.23-1.29 EPS. What price target have analysts set for HQY? 11 equities research analysts have issued 1 year price targets for Healthequity's shares. Their predictions range from $77.00 to $105.00. On average, they expect Healthequity's stock price to reach $90.3636 in the next twelve months. This suggests a possible upside of 32.3% from the stock's current price. View Analyst Price Targets for Healthequity. What is the consensus analysts' recommendation for Healthequity? 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 2 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Healthequity. What are Wall Street analysts saying about Healthequity stock? Here are some recent quotes from research analysts about Healthequity stock: 1. According to Zacks Investment Research, "Strong growth in Service and Custodial revenue segments buoy optimism HealthEquity. Notably, solid growth in HSAs and custodial assets provided a boost to the company’s top-line performance. Currently, HealthEquity is the second-largest HSA custodian in terms of market share. These apart, HealthEquity’s 401(K) solution, which lowers the cost, risk and work of managing a retirement plan, bodes well for the company. Moreover, management is optimistic about the launch of HealthEquity retirement services. Reflective of the trends exhibited by the company, the stock outperformed its industry year to date. On the flip side, HealthEquity faces stiff competition in Medical Services markets. HealthEquity is required to comply with strict Treasury Regulations formulated by the Internal Revenue Service or the IRS." (5/21/2019) 2. Cantor Fitzgerald analysts commented, ". We are upgrading the shares of from Neutral. Our price target remains $82, or roughly 38% above current levels. HQY shares have struggled since the company reported F3Q19 results earlier this month. We believe fundamentals remain strong as HQY continues to benefit from continued adoption of health savings accounts (HSA). The company continues to grow above market rates. In the most recent quarter, HQY’s HSA members grew by 22%, which compares with Webster Bank, which reported account growth of just 12%. Earnings continue to benefit from a higher interest environment, even with a slight moderation in 10-year interest rates lately." (12/17/2018) Has Healthequity been receiving favorable news coverage? News headlines about HQY stock have been trending somewhat positive this week, according to InfoTrie. The research group identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Healthequity earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. Who are some of Healthequity's key competitors? Some companies that are related to Healthequity include LYFT (LYFT), Broadridge Financial Solutions (BR), Akamai Technologies (AKAM), WEX (WEX), Fair Isaac (FICO), Zillow Group (Z), Zillow Group (ZG), The Western Union (WU), Nielsen (NLSN), Alliance Data Systems (ADS), Etsy (ETSY), Farfetch (FTCH), CDK Global (CDK), GrubHub (GRUB) and athenahealth (ATHN). What other stocks do shareholders of Healthequity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Healthequity investors own include Input Capital (INP), Circle Oil (COP), Falcon Oil & Gas (FO), Shopify (SHOP), Ivanhoe Mines (IVN), NVIDIA (NVDA), Micron Technology (MU), Alibaba Group (BABA), Netflix (NFLX) and Square (SQ). Who are Healthequity's key executives? Healthequity's management team includes the folowing people: Mr. Jon Kessler, Pres, CEO & Director (Age 51)Stephen D. Neeleman, Founder & Vice Chairman (Age 51)Mr. Darcy G. Mott, Exec. VP & CFO (Age 66)Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 46)Mr. William Robert Otten, Exec. VP of Sales (Age 54) Who are Healthequity's major shareholders? Healthequity's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Morgan Stanley (10.43%), BlackRock Inc. (10.29%), FMR LLC (4.60%), Wasatch Advisors Inc. (3.26%), Janus Henderson Group PLC (2.89%) and Jackson Square Partners LLC (2.78%). Company insiders that own Healthequity stock include Angelique Christine Hill, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan and Stephen Neeleman. View Institutional Ownership Trends for Healthequity. Which major investors are selling Healthequity stock? HQY stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, FMR LLC, Eagle Asset Management Inc., BlackRock Inc., Carillon Tower Advisers Inc., OppenheimerFunds Inc., Voya Investment Management LLC and Stephens Investment Management Group LLC. Company insiders that have sold Healthequity company stock in the last year include Angelique Christine Hill, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici and Gary D Robinson. View Insider Buying and Selling for Healthequity. Which major investors are buying Healthequity stock? HQY stock was bought by a variety of institutional investors in the last quarter, including Jackson Square Partners LLC, Wasatch Advisors Inc., Wells Fargo & Company MN, SEI Investments Co, Macquarie Group Ltd., American Capital Management Inc., Moody Lynn & Lieberson LLC and Ashford Capital Management Inc.. View Insider Buying and Selling for Healthequity. How do I buy shares of Healthequity? Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Healthequity's stock price today? One share of HQY stock can currently be purchased for approximately $68.30. How big of a company is Healthequity? Healthequity has a market capitalization of $4.28 billion and generates $287.24 million in revenue each year. The company earns $73.90 million in net income (profit) each year or $0.95 on an earnings per share basis. Healthequity employs 1,141 workers across the globe. What is Healthequity's official website? The official website for Healthequity is http://www.healthequity.com/. How can I contact Healthequity? Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected] MarketBeat Community Rating for Healthequity (NASDAQ HQY)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 344 (Vote Outperform)Underperform Votes: 273 (Vote Underperform)Total Votes: 617MarketBeat's community ratings are surveys of what our community members think about Healthequity and other stocks. Vote "Outperform" if you believe HQY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: Producer Price Index (PPI) Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.